Loneliness at 50+: The role of demographic and socioeconomic factors. by Sophie Guthmuller (9955408)

“…<p>Note: The figure displays odds ratios of individual socioeconomic and demographic variables at age 50+ for three different specifications. Specification (3) includes D, a set of individual socioeconomic and demographic variables at age 50+; P, a vector of the five scores of personality traits (extraversion, agreeableness, conscientiousness, neuroticism, openness); C, a vector of childhood circumstances (wealth; health; quality of the relationship with mother, father, and friends; importance of religion), and I, country-specific fixed effects. …”

Plausibility of the zebrafish embryos/larvae as an alternative animal model for autism: A comparison study of transcriptome changes by Sangwoo Lee (1727713)

“…We found that 100 μM and 50 μM valproic acid decreased the hatching rate and locomotor activity of zebrafish embryos/larvae. …”

Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

Total numbers of genes and numbers of genes with at least a twofold increase or decrease in gene expression in SF tissues. by Yasuhiko Murata (165491)

Correlation between urinary Br- levels and ERP indices in all participants before (n = 50) and after (n = 50) work. by Jungmi Choi (4740150)

cAMP and PKA/AKAP1 decrease mobility and promote mitochondrial translocation of Drp1. by Ronald A. Merrill (224222)

Identification of Small Molecules that Disrupt Signaling between ABL and Its Positive Regulator RIN1 by Pamela Y. Ting (713174)

“…The CML cell line K562 was then used to identify five compounds that decrease MAPK1/3 phosphorylation, which we determined to be an indicator of RIN1-dependent ABL signaling. …”

Compounds decrease polyQ toxicity in a <i>pqe-1</i> independent manner in aged animals. by Cindy Voisine (30589)

Forced activation of STAT1 causes a significant decrease in IFN-λ expression during IAV infection. by Haitao Wei (505384)

Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

“…<p>(A) In order to avoid overlap of the heavy chain signal (∼50 kDa) with the βIII-tubulin signal (∼55 kDa) in the immunoprecipitation using the Capzb2 monoclonal antibody (mAb), the antibody was coupled to the protein G/A beads through cross-linking. βIII-tubulin and Capzb2 signals were each detected following immunoprecipitation from brain lysate with both βIII-tubulin rabbit antibody (rAb)-coupled beads and Capzb2 mAb-coupled beads. …”

BH3 Peptides induces a decrease in mitochondrial membrane potential but does not engage the Permeability Transition Pore. by Emelyn H. Shroff (163459)

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

Effect of dilution and DMSO concentration on the interaction of NF-κB/DNA complex with the inhibitors. by Rodrigo Villagomez (685829)

MiR-20a overexpression decreases LIMK1 protein expression in thyroid cancer cell lines. by Yin Xiong (342546)

Persistent organic pollutant exposures are associated with liver toxicity and decreased albumin in a highly exposed human cohort by Matthew Cave (9148916)

Expression of Aβ42 decreases K_v4 protein and currents in the intact brain. by Yong Ping (233004)

Decreased IFNγ production by Ly49H⁺ NK cells in A/J mice. by Nassima Fodil (669326)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC₅₀ concentration of fenretinide during different time points (24–48–72 hours). …”

Pre-treatment with CDDO-Me decreases IR-induced DNA damage in a variety of non-cancerous cells. by Mariam El-Ashmawy (678638)

“…(A) HBEC 3KT, (B) HME1, and (C) PBMCs were treated with CDDO-Me 18 hours prior to IR, then mounted on slides 30 min post-IR. …”

Prevalence of antimicrobial resistance to folate pathway inhibitors exhibits a decreasing linear trend from 2002–2016. by Kelly E. Davidson (5464472)